AVH
AVITA MEDICAL CDI 5:1AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.
AVH
AVH
AVITA MEDICAL CDI 5:1
AVITA Medical, Inc. , together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | 0.30% | — |
| 10 July | 0.31% | — |
| 9 July | 0.29% | — |
| 8 July | 0.29% | — |
| 7 July | 0.26% | — |
| 6 July | 0.28% | — |
| 3 July | 0.29% | — |
| 2 July | 0.28% | — |
| 1 July | 0.29% | — |
Avita Medical CDI 5:1 (AVH) Short Interest Summary
Avita Medical CDI 5:1 (AVH) currently has 0.30% of its shares sold short (255 thousand shares, worth approximately $340K), based on ASIC short position data reported on 13 July 2026 (T+4 reporting lag). That makes AVH the #377 most shorted stock on the ASX most shorted list. Short interest in AVH is up 0.01% over the past week and down 0.10% over the past month. AVH is part of the Health Care sector on the ASX.
Recent AVH Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 13 July 2026 | 0.30% | 0.3M | $1.15 |
| 10 July 2026 | 0.31% | 0.3M | $1.24 |
| 9 July 2026 | 0.29% | 0.2M | $1.34 |
| 8 July 2026 | 0.29% | 0.2M | $1.40 |
| 7 July 2026 | 0.26% | 0.2M | $1.43 |
| 6 July 2026 | 0.28% | 0.2M | $1.39 |
| 3 July 2026 | 0.29% | 0.2M | $1.39 |
| 2 July 2026 | 0.28% | 0.2M | $1.35 |
| 1 July 2026 | 0.29% | 0.2M | $1.17 |
| 30 June 2026 | 0.31% | 0.3M | $1.20 |
AVH Short Selling — Frequently Asked Questions
What is Avita Medical CDI 5:1 (AVH)'s current short interest?
Avita Medical CDI 5:1 (AVH) currently has a short interest of 0.30% of total shares outstanding. This means 0.30% of AVH's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is AVH heavily shorted on the ASX?
AVH has a relatively low short interest of 0.30%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for AVH investors?
Short interest in AVH shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.30%, AVH's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this AVH short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for AVH.